Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2016 (2016), Article ID 3475235, 6 pages
http://dx.doi.org/10.1155/2016/3475235
Research Article

Synthesis and Evaluation of Mannitol-Based Inhibitors for Lipopolysaccharide Biosynthesis

Centre for Analysis and Synthesis, Lund University, P.O. Box 124, 221 00 Lund, Sweden

Received 8 November 2015; Revised 6 January 2016; Accepted 17 January 2016

Academic Editor: Patrick J. Bednarski

Copyright © 2016 Richard E. Johnsson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Payne, “Desperately seeking new antibiotics,” Science, vol. 321, no. 5896, pp. 1644–1645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Walker, S. Barrett, S. Polasky et al., “Looming global-scale failures and missing institutions,” Science, vol. 325, no. 5946, pp. 1345–1346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Spellberg, M. Blaser, R. J. Guidos et al., “Combating antimicrobial resistance: policy recommendations to save lives,” Clinical Infectious Diseases, vol. 52, no. 5, pp. S397–S428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. S. Gold and R. C. Moellering Jr., “Antimicrobial-drug resistance,” The New England Journal of Medicine, vol. 335, no. 19, pp. 1445–1453, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Fischbach and C. T. Walsh, “Antibiotics for emerging pathogens,” Science, vol. 325, no. 5944, pp. 1089–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Taubes, “The bacteria fight back,” Science, vol. 321, no. 5887, pp. 356–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Yethon and C. Whitfield, “Lipopolysaccharide as a target for the development of novel therapeutics in Gram-negative bacteria,” Current Drug Targets: Infectious Disorders, vol. 1, no. 2, pp. 91–106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Nikaido, “Prevention of drug access to bacterial targets: permeability barriers and active efflux,” Science, vol. 264, no. 5157, pp. 382–388, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gronow and H. Brade, “Lipopolysaccharide biosynthesis: which steps do bacteria need to survive?” Journal of Endotoxin Research, vol. 7, no. 1, pp. 3–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. R. H. Raetz and C. Whitfield, “Lipopolysaccharide endotoxins,” Annual Review of Biochemistry, vol. 71, pp. 635–700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. W. G. Coleman Jr. and L. Leive, “Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane,” Journal of Bacteriology, vol. 139, no. 3, pp. 899–910, 1979. View at Google Scholar · View at Scopus
  12. M. N. Alekshun and S. B. Levy, “Targeting virulence to prevent infection: to kill or not to kill?” Drug Discovery Today: Therapeutic Strategies, vol. 1, no. 4, pp. 483–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Kneidinger, C. Marolda, M. Graninger et al., “Biosynthesis pathway of ADP-L-glycero-β-D-manno-heptose in Escherichia coli,” Journal of Bacteriology, vol. 184, no. 2, pp. 363–369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Valvano, P. Messner, and P. Kosma, “Novel pathways for biosynthesis of nucleotide-activated glycero-manno-heptose precursors of bacterial glycoproteins and cell surface polysaccharides,” Microbiology, vol. 148, no. 7, pp. 1979–1989, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Kuznetsova, M. Proudfoot, C. F. Gonzalez et al., “Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family,” The Journal of Biological Chemistry, vol. 281, no. 47, pp. 36149–36161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ginsburg and A. H. Mehler, “Specific anion binding to fructose diphosphate aldolase from rabbit muscle,” Biochemistry, vol. 5, no. 8, pp. 2623–2634, 1966. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Ingram, “The combining sites of yeast fructose diphosphate aldolase,” Biochemical and Biophysical Research Communications, vol. 38, no. 4, pp. 624–630, 1970. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Marcus, “Inhibition of bovine hepatic fructose-1,6-diphosphatase by substrate analogs,” Journal of Biological Chemistry, vol. 251, no. 10, pp. 2963–2966, 1976. View at Google Scholar · View at Scopus
  19. C.-G. Mabiala-Bassiloua, M. Zwolinska, H. Therisod, J. Sygusch, and M. Therisod, “Separate synthesis and evaluation of glucitol bis-phosphate and mannitol bis-phosphate, as competitive inhibitors of fructose bis-phosphate aldolases,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 5, pp. 1735–1737, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Metzke and Z. Guan, “Structure-property studies on carbohydrate-derived polymers for use as protein-resistant biomaterials,” Biomacromolecules, vol. 9, no. 1, pp. 208–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-C. Matos and P. V. Murphy, “Synthesis of macrolide-saccharide hybrids by ring-closing metathesis of precursors derived from glycitols and benzoic acids,” Journal of Organic Chemistry, vol. 72, no. 5, pp. 1803–1806, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Wong and R. J. Cox, “The chemical mechanism of D-1-deoxyxylulose-5-phosphate reductoisomerase from Escherichia coli,” Angewandte Chemie—International Edition, vol. 46, no. 26, pp. 4926–4929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. H. H. Nguyen, L. Wang, H. Huang, E. Peisach, D. Dunaway-Mariano, and K. N. Allen, “Structural determinants of substrate recognition in the HAD superfamily member D-glycero-D-manno-heptose-1,7-bisphosphate phosphatase (GmhB),” Biochemistry, vol. 49, no. 6, pp. 1082–1092, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Desmond Molecular Dynamics System, Version 3.1, D. E. Shaw Research, New York, NY, USA, 2012.
  25. Maestro-Desmond Interoperability Tools, Version 3.1, Schrödinger, New York, NY, USA, 2012.
  26. The PyMOL Molecular Graphics System, Version 1.5.0.4, Schrödinger, LLC, New York, NY, USA, 2013.
  27. M. Durka, A. Tikad, R. Périon et al., “Systematic synthesis of inhibitors of the two first enzymes of the bacterial heptose biosynthetic pathway: towards antivirulence molecules targeting lipopolysaccharide biosynthesis,” Chemistry—A European Journal, vol. 17, no. 40, pp. 11305–11313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. G. C. Shih, C. M. Kahler, R. W. Carlson, M. M. Rahman, and D. S. Stephens, “gmhX, a novel gene required for the incorporation of l-glycero-d-manno-heptose into lipooligosaccharide in Neisseria meningitidis,” Microbiology, vol. 147, part 8, pp. 2367–2377, 2001. View at Publisher · View at Google Scholar